CLINICAL_TRIALS
trial_result
· 2015-10-12
Clinical Trial Update: Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients [Phase 2]
Summary
This update reports Phase 2 results on safety, tolerability, and pharmacokinetics of serelaxin in Japanese patients with acute heart failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2015-10-12